Menu
ÚHKT

Impaktované publikace

[41]

Dostalova Merkerova, M.; Krejcik, Z.; Votavova, H.; Belickova, M.; Vasikova, A.; Cermak, J.

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

[rok vydání 2010, impact factor 4.400]

[42]

Dostalova Merkerova, M.; Klema, J.; Kundrat, D.; Szikszai, K.; Krejcik, Z.; Hrustincova, A.; Trsova, I.; Le, A.V.; Cermak, J.; Jonasova, A.; Belickova, M.

Noncoding RNAs and their response predictive value in azacitidine-treated patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes

[rok vydání 2022, impact factor 4.069 ]

[43]

Chrastinová, L.; Pastva, O.; Bocková, M.; Lynn, N.S.; Šácha, P.; Hubálek, M.; Suttnar, J.; Kotlín, R.; Štikarová, J.; Hlaváčková, A.; Pimková, K.; Čermák, J.; Homola, J.; Dyr, J.E.

A new approach for the diagnosis of myelodysplastic syndrome subtypes based on protein interaction analysis

[rok vydání 2019, impact factor 3.998 ]

[44]

Votavova, H.; Grmanova, M.; Dostalova Merkerova, M.; Belickova, M.; Vasikova, A.; Neuwirtova, R.; Cermak, J.

Differential expression of microRNAs in CD34+ cells of 5q- syndrome

[rok vydání 2011, impact factor 3.990 ]

[45]

Sarova, I.; Brezinova, J.; Zemanova, Z.; Bystricka, D.; Krejcik, Z.; Soukup, P.; Cetkovsky, P.; Vydra, J.; Cermak, J.; Jonasova, A.; Michalova, K.

Characterization of chromosome 11 breakpoints and the areas of deletions and amplifications in newly diagnosed acute myeloid leukemia

[rok vydání 2012, impact factor 3.836 ]

[46]

Pimková, K.; Bocková, M.; Hegnerová, K.; Suttnar, J.; Čermák, J.; Homola, J.; Dyr, J.E.

Surface plasmon resonance biosensor for the detection of VEGFR-1-a protein marker of myelodysplastic syndromes

[rok vydání 2011, impact factor 3.659 ]

[47]

Hengeveld, M.; Suciu, S.; Chelgoum, Y.; Marie, J.-P.; Muus, P.; Lefrere, F.; Mandelli, F.; Pane, F.; Amadori, S.; Fioritoni, G.; Labar, B.; Baron, F.; Cermak, J.; Bourhis, J.-H.; Storti, G.; Fazi, P.; Hagemeijer, A.; Vignetti, M.; Willemze, R.; De Witte, T.

High numbers of mobilized CD34+cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT

[rok vydání 2015, impact factor 3.636 ]

[48]

Dostalova Merkerova, M.; Bystricka, D.; Belickova, M.; Krejcik, Z.; Zemanova, Z.; Polak, J.; Hajkova, H.; Brezinova, J.; Michalova, K.; Cermak, J.

From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype

[rok vydání 2011, impact factor 3.546 ]

[49]

Pimková, K.; Chrastinová, L.; Suttnar, J.; Štikarová, J.; Kotlín, R.; Čermák, J.; Dyr, J.E.

Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload

[rok vydání 2014, impact factor 3.516 ]

[50]

Pecankova, K.; Pecherkova, P.; Gasova, Z.; Sovova, Z.; Riedel, T.; Jäger, E.; Cermak, J.; Majek, P.

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

[rok vydání 2022, impact factor 3.240 ]

[51]

Haškovec, C.; Ponzetto, C.; Polák, J.; Maritano, D.; Zemanová, Z.; Serra, A.; Michalová, K.; Klamová, H.; Čermák, J.; Saglio, G.

P230 BCR/ABL protein may be associated with an acute leukaemia phenotype

[rok vydání 2006, impact factor 3.209]

[52]

Jonasova, A.; Neuwirtova, R.; Cermak, J.; Vozobulova, V.; Mocikova, K.; Siskova, M.; Hochova, I.

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

[rok vydání 2008, impact factor 3.209]

[53]

Polák, J.; Zemanová, Z.; Michalová, K.; Klamová, H.; Čermák, J.; Haškovec, C.

A new case of chronic myeloid leukemia (CML) in myeloid blast crisis with an atypical (b3/a3) junction of the BCR/ABL gene

[rok vydání 2006, impact factor 3.163]

[54]

Cukrová, V.; Neuwirtová, R.; Doležalová, L.; Beličková, M.; Bartůňková, J.; Jonášová, A.; Čermák, J.; Homolková, H.; Malíková, I.

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

[rok vydání 2009, impact factor 3.106]

[55]

Volejnikova, J.; Vojta, P.; Urbankova, H.; Mojzikova, R.; Horvathova, M.; Hochova, I.; Cermak, J.; et al.

Czech and Slovak Diamond-Blackfan Anemia (DBA) Registry update: clinical data and novel causative genetic lesions

[rok vydání 2020, impact factor 3.039 ]

[56]

Marinov, I.; Kohoutová, M.; Tkáčová, V.; Pešek, A.; Čermák, J.; Cetkovský, P.

Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry

[rok vydání 2013, impact factor 2.955 ]

[57]

Šárová, I.; Březinová, J.; Zemanová, Z.; Gančarčíková, M.; Vydra, J.; Čermák, J.; Michalová, K.

A novel gene LRP5 on 11q13.2 is rearranged in two patients with acute myeloid leukemia

[rok vydání 2011, impact factor 2.923 ]

[58]

Klener, P.Jr.; Leahomschi, S.; Molinsky, J.; Simonova, T.; Necas, E.; Gasova, Z.; Cermak, J.; Dolezalova, L.; Andera, L.; Zivny, J.

TRAIL-induced apoptosis of HL60 leukemia cells : two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine

[rok vydání 2008, impact factor 2.901]

[59]

Fuchs, O.; Kostecka, A.; Provaznikova, D.; Krasna, B.; Brezinova, J.; Filkukova, J.; Kotlin, R.; Kouba, M.; Kobylka, P.; Neuwirtova, R.; Jonasova, A.; Caniga, M.; Schwarz, J.; Markova, J.; Maaloufova, J.; Sponerova, D.; Novakova, L.; Cermak, J.

Nature of frequent deletions in CEBPA

[rok vydání 2009, impact factor 2.901]

[60]

Indrak, K.; Brabec, V.; Indrakova, J.; Chrobak, L.; Sakalova, A.; Jarosova, M.; Cermak, J.; Fei, Y.J.; Kutlar, F.; Gu, Y.C.

Molecular characterization of beta-thalassemia in Czechoslovakia

[rok vydání 2006, impact factor 2.877]